Evaluation of the Effectiveness of a Product Containing Topical Hydrocortisone in the Treatment of Seborrheic Dermatitis of the Face (13244/2009)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01024374 |
Recruitment Status : Unknown
Verified December 2009 by Allergisa Pesquisa Dermato-Cosmetica LTDA.
Recruitment status was: Not yet recruiting
First Posted : December 2, 2009
Last Update Posted : December 2, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Clinical single-blind randomized comparison with the overall objective of evaluating the clinical efficacy of the products Nutracort lotion and Nutracort cream in the treatment of seborrheic dermatitis on the face.
Will be held clinical and perceived efficacy assessment and instrumental measurements. Each product will be applied at half face for 7 consecutive days and all applications will be monitored in the research site. 60 volunteers will be recruited.
Evaluations will be held at the following times: T0 - before the initial application of the product; T1 - 24 hours after starting treatment, T2 - 48 hours after starting treatment, T3 - 72 hours after initiation of treatment, T4 - 96 hours after the start treatment, T7 - 7 days after initiation of treatment.
Condition or disease |
---|
Seborrheic Dermatitis |
Study Type : | Observational |
Estimated Enrollment : | 60 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Avaliação da eficácia de um Produto de Uso tópico Contendo Hidrocortisona no Tratamento de Dermatite seborréica na Face. |
Study Start Date : | April 2010 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Healthy subjects
- Subjects with seborrheic dermatitis on both sides of the face
- both sexes
- aged 18 to 60 years
- skin types I through IV.
Exclusion Criteria:
- pregnancy / lactation
- skin condition in the area of application of the product
- diabetes
- immune insufficiency
- subjects that are using systemic corticoids
- subjects that are using immunosuppressors
- skin diseases: vitiligo, psoriasis, lupus, atopic dermatitis
- history of reaction to the product category
- other diseases or medications that might interfere directly in the study or endanger the health of the subject
Responsible Party: | Douglas - P&D, Galderma |
ClinicalTrials.gov Identifier: | NCT01024374 |
Other Study ID Numbers: |
All-E-M-13244-01/02-10-09 |
First Posted: | December 2, 2009 Key Record Dates |
Last Update Posted: | December 2, 2009 |
Last Verified: | December 2009 |
Dermatitis Dermatitis, Seborrheic Skin Diseases |
Sebaceous Gland Diseases Skin Diseases, Eczematous Skin Diseases, Papulosquamous |